Pentoxifylline inhibits replication of Japanese encephalitis virus: a comparative study with ribavirin

International Journal of Antimicrobial Agents

Volumn 33, Issue 2, 2009, Pages 168-173

  Sebastian, Liba ^a   Desai, Anita ^a   Madhusudana, Shampur Narayan ^a   Ravi, Vasanthapuram ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

Antiviral agents; Japanese encephalitis virus; Pentoxifylline; Ribavirin

Indexed keywords

MESSENGER RNA; PENTOXIFYLLINE; RIBAVIRIN;

ANIMAL EXPERIMENT; ANTIVIRAL ACTIVITY; ANTIVIRAL THERAPY; ARTICLE; CONTROL GROUP; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG SCREENING; ENCEPHALITIS VIRUS; EXPERIMENTAL MOUSE; IC 50; IN VITRO STUDY; IN VIVO STUDY; JAPANESE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; CYTOPATHOGENIC EFFECT, VIRAL; ENCEPHALITIS VIRUS, JAPANESE; ENCEPHALITIS, JAPANESE; INHIBITORY CONCENTRATION 50; MICE; MICROBIAL SENSITIVITY TESTS; PENTOXIFYLLINE; PLAQUE ASSAY; RIBAVIRIN; SURVIVAL ANALYSIS; VIRUS REPLICATION;

EID: 58149197807     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2008.07.013     Document Type: Article

References (20)

1. Chen C.J., Raung S.L., Kuo M.D., and Wang Y.M. Suppression of Japanese encephalitis virus infection by non-steroidal anti-inflammatory drugs. J Gen Virol 83 (2002) 1897-1905
2. Kalita J., and Misra U.K. EEG in Japanese encephalitis: a clinico-radiological correlation. Electroencephalogr Clin Neurophysiol 106 (1998) 238-243
3. Misra U.K., Kalita J., and Srivastava M. Prognosis of Japanese encephalitis: a multivariate analysis. J Neurol Sci 161 (1998) 143-147
4. Leyssen P., Erik D.C., and Johan N. Perspectives for treatment of infections with Flaviviridae. Clin Microbiol Rev 13 (2000) 67-82
5. Huh P.D., Kotasek H.S., Jacob G.M., Vercellotti, and Hammerschimidt D.E. Mechanism of action of pentoxifylline in peripheral vascular disease: inhibition of platelet and granulocyte responsiveness. Clin Res 33 (1985) 866-878
6. Amvros'eva T.V., Votiakov V.I., Andreeva O.T., Vladyko G.V., Nikolaeva S.N., and Orlova S.V. New properties of trental as an inhibitor of viral activity with a wide range of activity [in Russian]. Vopr Virusol 38 (1993) 230-233
7. Fazely F., Dezube B.J., Ryan J., Pardee A.B., and Ruprecht R.M. Pentoxifylline (Trental) decreases the replication of the human immunodeficiency virus type 1 in human peripheral blood mononuclear cells and in cultured T cells. Blood 77 (1991) 1653-1656
8. Fox L.M., Kinter A.L., Poli G., and Fauci A.S. Pentoxifylline inhibits HIV replication in acutely infected primary cells and chronically infected U1 cells through multiple mechanisms. Program and Abstracts of the First National Conference on Human Retrovirus and Related Infections; December 12-16. Washington DC (1993) p. 119
9. Crance J.M., Scarmozzino N., Jouan A., and Garin D. Interferon, ribavirin, 6-azauridine and glycyrrhizin: antiviral compounds active against pathogenic flavivirus. Antiviral Res 57 (2003) 73-79
10. Sebastian L., Desai A., Madhusudana S.N., Yogeeswari Y., Sriram D., and Ravi V. N-methylisatin-β-thiosemicarbazone derivative (SCH 16) is an inhibitor of Japanese encephalitis virus infection in vitro and in vivo. Virol J 5 (2008) 64
11. Desai A., Ravi V., Guru S.C., Shankar S.K., Kaliaperumal V.G., Chandramuki A., et al. Detection of autoantibodies to neural antigens in the CSF of Japanese encephalitis patients and co-relation of findings with the outcome. J Neurol Sci 122 (1994) 109-116
12. Whitby K., Pierson T.C., Geiss B., Lane K., Engle M., Zhou Y., et al. Castanospermine, a potent inhibitor of dengue virus infection in vitro and in vivo. J Virol 79 (2005) 8698-8706
13. Shu P.Y., Chang S.F., Kuo Y.C., Yueh Y.Y., Chien L.J., Sue C.L., et al. Development of group and serotype specific one-step Syber Green-I based real time reverse transcription PCR assay for dengue virus. J Clin Microbiol 41 (2003) 2408-2416
14. Ravi V., Parida S., Desai A., Chandramukhi A., Gourie-Devi M., and Grau G.E. Correlation of tumor necrosis factor levels in the serum and cerebrospinal fluid with clinical outcome in Japanese encephalitis patients. J Med Virol 51 (1997) 132-136
15. Campbell I.L. Cytokines in viral disease. Curr Opin Immunol 3 (1991) 486-491
16. Schade U.F. Pentoxifylline increases survival in murine endotoxin shock and decreases formation of tumor necrosis factor. Circ Shock 31 (1990) 171-181
17. Martin J.F.B., Jimenez J.L., and Munoz-Fernandez M.A. Pentoxifylline and severe acute respiratory syndrome (SARS): a drug to be considered. Med Sci Monit 9 (2003) 41-46
18. Baginski S.G., Pevear D.C., Seipel M., Sun S.C.C., Benetatos C.A., Chunduru S.K., et al. Mechanism of action of a pestivirus antiviral compound. Proc Natl Acad Sci USA 97 (2000) 7981-7986
19. Hase T., Summers P.L., and Dubois D.R. Ultrastructural changes of mouse brain neurons infected with Japanese encephalitis virus. Int J Exp Pathol 71 (1990) 493-505
20. Chen G., and Goeddel D.V. TNF-R1 signaling: a beautiful pathway. Science 296 (2002) 1634-1635